Validating a score to find hidden cancer in blood clot patients
Part of Heart & circulation clinical trials.
This study tests how well a scoring system (CLOVER) can detect undiagnosed cancer in people who have had a blood clot (deep vein thrombosis or pulmonary embolism). Researchers want to see if the score can predict hidden cancer, which may lead to earlier treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with a recent, acute blood clot in a vein (deep vein thrombosis or a pulmonary embolism)
- You are able to give written or electronic permission to take part in the study
- You are not known to have cancer at the time of your blood clot evaluation
- You are not currently enrolled in another study that could affect the results
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows adults who may have a blood clot in the lung (pulmonary embolism) or leg (deep vein thrombosis), or who were found to have a clot by chance. It aims to improve how doctors diagnose, manage, and estimate risk, which may lead to better, more tailored care for you.
This trial tests a new anticoagulant medication to treat and prevent blood clots in patients with active cancer. You may qualify if you have a recent clot in your leg or lungs and are already taking a blood thinner.
This study looks for “biomarkers,” or blood signs, that may help detect hidden (occult) cancer in people who recently had a blood clot in the leg or a lung clot. It may help doctors catch cancer earlier by improving detection after venous thromboembolism.
This study is for people with cancer who have had a serious blood clot. Researchers want to create a risk score that predicts who might have another clot or a bleeding problem from treatment, so they can better tailor care.
This study follows people who have both cancer and a blood clot. It aims to learn more about how these clots happen and how they are treated in cancer patients, so doctors can improve care.
This study looks at how people with cancer-related blood clots in the leg or lungs do with anticoagulant (blood thinner) treatment over at least 3 months. It also tracks quality of life and healthcare use, which may help improve supportive care for patients.
Hear when a new Venous Thromboembolism (VTE) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.